Technology
 |
The KiNativ™ platform provides the unprecedented ability to broadly and quantitatively profile protein and lipid kinases in virtually any cell/tissue lysate. KiNativ website |
 |
ActivX has pioneered the development of active site probes to facilitate drug discovery and development efforts for targets in a variety of enzyme families including kinases, serine hydrolases, GTPases, and cathepsins. ActivX Targeted Probes website. |
